Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abortion, spontaneous
acetylcholine
acetylcholine receptor
acetylcholine receptor antibody
acetylcholine receptor antibody, ganglionic
adverse drug reaction
agammaglobulinemia
algorithm
alpha methyltyrosine
alpha-fetoprotein
Alzheimer's disease
ANA
anesthesia, general
anesthesia, local
anticholinergic drugs
anticholinesterase
antimetabolite
antistriational muscle antibody
aspiration
autoantibodies
autoimmune disease
autonomic dysfunction
autonomic neuropathy
autonomic neuropathy, idiopathic
azathioprine
Bell's phenomenon
biologic markers
blacks
breast feeding
carcinoma
carcinoma of lung
CAT scan
CAT scan, abnormal
CAT scan, emission, abnormal
central nervous system, infection of
cerebral edema
cerebrospinal fluid, elevated protein of
cesarean section
children
choking
chronic progressive external ophthalmoplegia
Clinical Pathologic Conference(C.P.C.)
clonazepam
Collier's sign
coma
comorbidities
complications
congenital myasthenic syndromes
critical care unit
cyclosporine
cytokines
cytomegalovirus infection
dabrafenib
deanol
delay in diagnosis
diplopia
diplopia, transient
dopamine
dopamine antagonist
dropped head syndrome
drug induced neurologic disorders
drug interactions
dysarthria
dysphagia
dysphonia
dyspnea
efgartigimod alfa
ejection fraction
electromyogram
electromyogram, decremental response
electron microscopy
encephalitis
encephalitis, brainstem
encephalomyelitis
encephalopathy
ephedrine
epidemiology of neurology
esophageal manometry
eye closure
falling
false positive
familial
fatigue
fever
floppy infant
gait disorder
gammaglobulin therapy, intravenous
genetic neurologic disorders
genetic testing
Graves ophthalmopathy
haloperidol
headache
hepatolenticular degeneration(Wilson's disease)
heralding manifestation
HLA
HMGcoA reductase inhibitors
hoarseness
hypercapnia
hypersomnia
hypokinetic left ventricle
hypophonia
hypotonia
hypotonia, infants
iatrogenic neurologic disorders
immune checkpoint inhibitors
immune-related adverse events
immunohistochemistry
immunologic disease
immunology and the nervous system
immunosuppressive agents
interferon
intracranial pressure, increased
intubation
Kearns-Sayre syndrome
labor, complicated
Lancaster red-green tests of ocular motility
leg weakness, unilateral
leukocytosis
lid abnormalities
lid closure, weakness of
lid twitch
lipoprotein receptor-related protein 4
lithium
lymphadenitis
magnesium sulfate
Mary Walker phenomenon
mediastinum, mass of
mediastinum, widening
melanoma, malignant
meningoencephalitis
mestinon
misdiagnosis
mitochondrial disease
mitochondrial encephalomyopathy
monoclonal antibodies
mortality
muscle biopsy
muscle pain
muscle weakness
muscle weakness, proximal
MuSK antibodies
myasthenia gravis
myasthenia gravis, classification
myasthenia gravis, cold test for
myasthenia gravis, congenital
myasthenia gravis, diagnosis
myasthenia gravis, differential diagnosis
myasthenia gravis, distal weakness
myasthenia gravis, drug induced
myasthenia gravis, etiology of
myasthenia gravis, exacerbation
myasthenia gravis, familial incidence of
myasthenia gravis, infantile and juvenile
myasthenia gravis, late-onset
myasthenia gravis, limb-girdle
myasthenia gravis, misdiagnosis of
myasthenia gravis, neonatal
myasthenia gravis, neuromuscular junction in
myasthenia gravis, ocular
myasthenia gravis, paraneoplastic
myasthenia gravis, passive transfer of
myasthenia gravis, presenting manifestations
myasthenia gravis, prognosis of
myasthenia gravis, receptor site in
myasthenia gravis, remission of
myasthenia gravis, seronegative
myasthenia gravis, thymectomy in
myasthenia gravis, treatment of
myasthenia gravis, unmasked
myasthenia gravis, variants
myasthenic crisis
myasthenic syndrome
mycophenolate
myocarditis
myopathy
myositis
nasal speech
neck weakness
nerve conduction studies
neuroleptic
neurologic disease, diagnoses of
neurologic examination
neurologic history
neurologic signs
neurologic symptoms
neuromuscular blockade
neuromuscular disease, electrodiagnosis of
neuromuscular junction
neuromuscular junction, abnormality of
neuromyelitis optica (Devic's disease)
neuroophthalmology
neuropathy
neuropathy, etiologies of
next-generation sequencing
nystagmus
ocular motility, disorders of
old age, neurology of
ophthalmoplegia
papaverine
peek sign
penicillamine
phenothiazine
physostigmine
pimozide
plasmapheresis
pleocytosis of cerebrospinal fluid
pneumonia
polymyositis
practice guidelines
pregnancy, neurologic complications in
prognosis
prostigmine
pseudointernuclear ophthalmoplegia
pseudomyasthenia
ptosis
ptosis, asymmetric
ptosis, bilateral
ptosis, unilateral
pulmonary edema
pulmonary infiltrates
quality of life
quinine
radiation therapy, total body
ragged-red fibers
rash
rash, hand
remission
remote effect of cancer on the nervous system
repetitive nerve stimulation
reserpine and reserpine like drugs
respiratory depression
respiratory distress syndrome, neurologic status with
respiratory failure
review article
rheumatoid arthritis
rickettsial organism
rituximab
Rocky Mountain spotted fever
saccadic eye movements
saccadic eye movements, abnormal
serologic testing
serologic testing, false negative
serologic testing, false positive
seronegative
seropositive
serum tumor markers
single-fiber electromyography
sleep
spinal cord, lesion of
statin therapy
steroid
steroid therapy, CNS treatment and complications with
stillbirth
systemic lupus erythematosus
systemic lupus erythematosus, neonatal
systemic lupus erythematosus, neurologic complications with
tardive dyskinesia
tardive dyskinesia, treatment of
tensilon
tensilon test
tensilon test, false negative
tensilon test, false positive
tensilon test, paradoxical
tetrabenazine
thrombocytopenia
thymectomy
thymic hyperplasia
thymoma
thymus and neuromuscular function
thyroiditis
thyrotoxicosis
tick bite
tonsillar herniation of cerebellum
trametinib
transient neurologic deficit
treatment of neurologic disorder
uncal herniation
upgaze, paralysis of
vasculitides
viral infection
voice, abnormality of
walking, difficulty with
weakness
weakness, end of day
weakness, fatiguable
weakness, generalized
weakness, proximal
weight loss
whites
wide based gait
Showing articles 700 to 750 of 782 << Previous Next >>

Cerebrospinal Fluid Rhinorrhea Caused by Bromocriptine Therapy of Prolactinoma
Neurol 34:111-113, Holness,R.O.,et al, 1984

Treatment of Prolactinomas with Megavoltage Radiotherapy
BMJ 288:1105-1109, Grossman,A.,et al, 1984

Rapid Size Reduction of Giant Prolactinoma Following Medical Treatment
J Comput Assist Tomogr 8:131-133, Perani,D.,et al, 1984

Hyperprolactinemia
Am J Med 75:868-874, Johnston,D.G.,et al, 1983

Urinary Incontinence in Patient on Long-Term Bromocriptine
Lancet 2:1260-1261, Sandyk,R.,et al, 1983

Limbic Encephalopathy as a Nonmetastatic Complication of Oat Cell Lung Cancer
Am J Med 75:518-520, Brennan,L.V.,et al, 1983

Pergolide in Parkinson's Disease
Arch Neurol 40:785-787, Goetz,C.G.,et al, 1983

Myoclonus Induced by Metoclopramide Therapy
Arch Int Med 143:2201-2202, Hyser,C.G.,et al, 1983

Progressive Supranuclear Palsy:Clinical Features & Response to Treatment in 16 Patients
Ann Neurol 13:273-278, Jackson,J.A.,et al, 1983

Failure of Bromocriptine to Maintain Reduction in Size of a Macroprolactinoma
BMJ 287:451-452, Breidahl,H.D.,et al, 1983

Treatment of Acromegaly
BMJ 286:330-332, Thomas,J.P., 1983

Bromocriptine & Lisuride in Parkinson Disease
Ann Neurol 13:44-47, Lieberman,A.N.,et al, 1983

Comparison of Pergolide & Bromocriptine Therapy in Parkinsonism
Neurol 33:1009-1014, LeWitt,P.A.,et al, 1983

Neuroleptic Malignant Syndrome:Successful Treatment with Dantolene & Bromocriptine
Ann Neurol 14:89-90, Granato,J.E.,et al, 1983

Neuroleptic Malignant Syndrome, Successful Treatment with Bromocriptine
JAMA 249:386-388, Mueller,P.S.,et al, 1983

Lisuride Versus Bromocriptine Treatment in Parkinson Disease:A Double-blind Study
Neurol 32:69-72, LeWitt,P.A.,et al, 1982

Acute Akathisia After Oral Droperidol & Metoclopramide Preoperative Medication
Lancet 2:48-49, Barnes,T.R.E.,et al, 1982

Metoclopramide-Induced Parkinsonism
Arch Neurol 39:494-496, Indo,T.,et al, 1982

Neurotransmitters & CNS Disease, Dementia
Lancet 2:1200-1204, Rossor,M.N., 1982

A Plain Man's Guide to the Management of Migraine
BMJ 284:1095-1097, Blau,J.N., 1982

Domperidone in the Prevention of Complete Classical Migraine
BMJ 284:944, Waelkens,J., 1982

Bromocriptine Reduces Pituitary Tumor Size & Hyper-secretion
JAMA 247:311-316, Spark,R.F.,et al, 1982

CSF Rhinorrhea After Bromocriptine For Prolactinoma
NEJM 306:178, Baskin,D.S.,et al, 1982

Neurotransmitters & CNS Disease
Lancet 2:914-918, Iversen,L.L., 1982

Bromocriptine in Management of Large Pituitary Tumours
BMJ 284:1908-1911, Wass,J.A.H.,et al, 1982

Size Reduction of Extrasellar Pituitary Tumors During Bromocriptine Treatment
Ann Int Med 96:281-286, Wollesen,F.,et al, 1982

Reduction in Size of Prolactin-secreting Tumours in Men Treated with Pergolide
BMJ 285:465-467, Kendall-Taylor,P.,et al, 1982

Bromocriptine-induced psychosis in acromegaly
BMJ 285:1315, Lefeuvre,C.M.,et al, 1982

Bromocriptine:Low-dose Therapy in Parkinson Disease
Neurol 32:577-583, Teychenne,P.F.,et al, 1982

Pergolide Mesylate & Idiopathic Parkinson Disease
Neurol 32:1175-1179, Tanner,C.M.,et al, 1982

Pergolide in Late-Stage Parkinson Disease
Ann Neurol 12:243-247, Lang,A.E.,et al, 1982

Further Studies with Pergolide in Parkinson Disease
Neurol 32:1181-1184, Lieberman,A.N.,et al, 1982

Prolactinoma:A Question of Rational Treatment
BMJ 283:1561-1562, Edwards,C.R.W.,et al, 1981

Bromocriptine Therapy for"Nonfunctioning"Pituitary Tumors
Am J Med 71:1059-1061, Johnston,D.G.,et al, 1981

Bromocriptine In Acromegaly
NEJM 305:1092-1093, Thorner,M.O.,et al, 1981

Effect Of Bromocriptine On Brain Metastasis In Breast Cancer
Lancet 2:745-746, Grisoli,F.,et al, 1981

Lisuride in Parkinson Disease:Efficacy of Lisuride Compared to Levodopa
Neurol 31:961-965, Lieberman,A.N.,et al, 1981

No Effect Of Bromocriptine In Acromegaly
NEJM 304:1450-1454, Lindholm,J.,et al, 1981

Regression of Pituitary Prolactinoma With Bromocriptine Administration
JAMA 245:1149-1150, Velentzas,C.,et al, 1981

Mental Disorders From Low-Dose Bromocriptine
NEJM 305:173, Pearson,K.D., 1981

Bromocriptine & Domperidone in the Treatment of Parkinson Disease
Neurol 31:662-667, Quinn,N.,et al, 1981

Lisuride in Parkinsonism
Neurol 31:371-376, Gopinathan,G.,et al, 1981

Treatment of Advanced Parkinson Disease With Pergolide
Neurol 31:675-682, Lieberman,A.,et al, 1981

Extrapyramidal Side-Effects Of Metoclopramide
Lancet 2:1254-1255, Kataria,M.,et al, 1981

Parkinsonism & Tardive Dyskinesia Associated With Long-Term Metoclopramide Therapy
NEJM 305:1417, Grimes,J.D., 1981

Akinetic Mutism from Hypothalamic Damage:Successful Treatment with Dopamine Agonists
Neurol 31:1435-1439, Ross,E.D.,et al, 1981

Cimetidine Toxic Reactions Masquerading as Delirium Tremens
JAMA 245:1058-1059, Weddington,W.W.,et al, 1981

Cimetidine Interaction with Phenytoin
BMJ 282:1512, Hetzel,D.J.,et al, 1981

Increased Hair Loss As A Side Effect of Bromocriptine Treatment
NEJM 303:1418, Blum,I.,et al, 1980

Alcohol Increases Bromocriptine's Side Effects
NEJM 302:806, Ayres,J.,et al, 1980



Showing articles 700 to 750 of 782 << Previous Next >>